Read smarter, stay ahead of the pack


News at a Glance

Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit
The New York Times:
Johnson & Johnson has long been accused of downplaying certain risks in its marketing of the drug Risperdal.

7 days ago

Everleap Cloud Hosting - Free Trial
Rapid SSL About Us | Contact Us | Terms of Service | Privacy Policy | RSS Feed | Sign Up

© 2014-2019  BizDailies. All rights reserved.